Rivian Lowers Annual Delivery Forecast Again
Rivian sales jumped due to a tax credit rush, but they cut their yearly delivery forecast. Costs are rising, making future profits tough.

Already have an account? Sign in.
Rivian sales jumped due to a tax credit rush, but they cut their yearly delivery forecast. Costs are rising, making future profits tough.
JPMorgan raises RAPT stock rating to Overweight with $55 target after Phase 2 trial success. Stock jumps 17% on positive chronic urticaria treatment data.
Baird raises Alto Neuroscience price target to $16 as company secures $50M funding and FDA approval to fast-track ALTO-207 depression drug development.
Piper Sandler ups Riot Platforms price target to $25, citing potential hyperscaler deals to convert Texas bitcoin mining facilities into AI data centers.